<DOC>
	<DOCNO>NCT01500499</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood , tissue , bone marrow patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This research trial study role biomarkers disease progression sample patient acute myeloid leukemia .</brief_summary>
	<brief_title>Role Biomarkers Disease Progression Samples From Patients With Acute Myeloid Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - To determine subcellular localization MLL-AF1q fusion protein leukemia cell . OUTLINE : Cryopreserved specimen analyze MLL-AF1q fusion protein AF1 gene expression mass spectrometry , western blot analysis , semi-quantitative PCR , qPCR .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Cryopreserved acute myeloid leukemia specimens PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>adult acute myeloid leukemia</keyword>
	<keyword>childhood acute myeloid leukemia/other myeloid malignancy</keyword>
</DOC>